MRK vs BAX
By Alex · Tickerpine
Merck & Co., Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BAX |
|---|---|---|
| Price | $128.66 | $22.04 |
| Market cap | $317.77B | $11.38B |
| P/E ratio | 36.2 | — |
| ROE | 18.94% | -15.01% |
| Profit margin | 13.59% | -9.70% |
| Revenue growth | 4.90% | 2.90% |
| Dividend yield | 2.64% | 0.91% |
| Beta | 0.22 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BAX in plain English
- MRK is the bigger company — about 27.9× the market cap of BAX.
- MRK earns a higher return on equity (19% vs -15%).
- MRK is growing revenue faster (5% vs 3%).
- MRK has the higher dividend yield (2.64% vs 0.91%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.